Dr. Ronja Brinks possesses extensive experience in toxicology and regulatory affairs, having held positions such as Senior Manager Global Regulatory Affairs at LANXESS since November 2022 and Manager Toxicology at SysKem Chemie GmbH in July 2015. Research experience includes a role as a PhD Student at Universitätsklinikum Düsseldorf from September 2018 to September 2022, as well as contributing to the paediatric clinic in oncology and hematology. Dr. Brinks completed a Master Thesis on the eye irritation potential of surfactant mixtures at Henkel in 2017 and a Bachelor Thesis on Glycosyltransferase in Mycobacterium smegmatis. Academic qualifications include a Promotion in Pharmacy (Magna cum laude) and advanced studies in toxicology and biology from Heinrich-Heine University, Düsseldorf.
This person is not in any teams
This person is not in any offices